Page 82
Volume 08
Clinical Pharmacology & Biopharmaceutics
ISSN: 2167-065X
Pharmacology 2019
World Heart Congress 2019
August 19-20, 2019
JOINT EVENT
conferenceseries
.com
August 19-20, 2019 Vienna, Austria
&
7
th
World Heart Congress
24
th
World Congress on
Pharmacology
Evaluation of the effect of HFRT on the anthropometric obesity parameters in patients of chronic heart
failure-a retrospective analysis
Gurudatta Amin, Rohit Sane
and
Rahul Mandole
Madhavbaug Cardiac Care Clinics and Hospital, India
Statement of the Problem
: Chronic heart failure (CHF) is a common cause of mortality and morbidity. Obesity
influences the CHF development and prognosis. This study was conducted to assess effect of Heart failure reversal
therapy (HFRT), a combination of panchakarma and allied therapies, on anthropometric parameters in CHF patients.
Methodology & Theoretical Orientation
: This retrospective study was conducted on data of patients who visited
Madhavbaug clinics in Maharashtra, India between July-December 2018. Selection was based upon the availability
of complete baseline (day 1 of HFRT) and follow-up data (day 30 of HFRT) of CHF patients who were admitted for
minimum five days for HFRT.
Findings
: Out of 147 patients, 74.15%were males with mean age 59.15+10.28 years. There was statistically significant
decrease (p<0.05) in both mean BMI and abdominal girth at day 30 of HFRT. 42 of 147 patients (28.57%) had
hypertension (HTN) with CHF, 22 patients (14.97%) had diabetes mellitus (DM) and 61 patients (41.49%) had both
HTN and DM. In all these sub-groups, mean BMI and abdominal girth was significantly decreased (p<0.05) at day
30. Strong positive correlation was found between BMI and abdominal girth on day 1 (R=0.9, P<0.05) and day 30
(R=0.83, P<0.05) by Pearson’s correlation. Similar correlation was found between the two parameters in subsets of
CHF patients having HTN or DM or both DM and HTN (p<0.05).
Conclusion & Significance
: HFRT decreased BMI and abdominal circumference significantly in CHF patients,
irrespective of the presence of HTN or DM. Both the anthropometric parameters correlated strongly in all co-
morbidity subsets of CHF patients.
Clin Pharmacol Biopharm, Volume 08